KSQ Therapeutics Company
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Technology:
Biologics
Industry:
Gene therapy
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2015
Employees Number:
11-50
Funding Status:
Late Stage Venture
Total Funding:
156000000
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series C
Register and Claim Ownership